1. Home
  2. COGT vs LVWR Comparison

COGT vs LVWR Comparison

Compare COGT & LVWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COGT
  • LVWR
  • Stock Information
  • Founded
  • COGT 2014
  • LVWR 2022
  • Country
  • COGT United States
  • LVWR United States
  • Employees
  • COGT N/A
  • LVWR N/A
  • Industry
  • COGT Biotechnology: Pharmaceutical Preparations
  • LVWR
  • Sector
  • COGT Health Care
  • LVWR
  • Exchange
  • COGT Nasdaq
  • LVWR Nasdaq
  • Market Cap
  • COGT 984.0M
  • LVWR 1.2B
  • IPO Year
  • COGT 2018
  • LVWR N/A
  • Fundamental
  • Price
  • COGT $8.90
  • LVWR $5.97
  • Analyst Decision
  • COGT Buy
  • LVWR Hold
  • Analyst Count
  • COGT 6
  • LVWR 1
  • Target Price
  • COGT $14.67
  • LVWR $7.25
  • AVG Volume (30 Days)
  • COGT 1.3M
  • LVWR 21.3K
  • Earning Date
  • COGT 11-12-2024
  • LVWR 10-24-2024
  • Dividend Yield
  • COGT N/A
  • LVWR N/A
  • EPS Growth
  • COGT N/A
  • LVWR N/A
  • EPS
  • COGT N/A
  • LVWR N/A
  • Revenue
  • COGT N/A
  • LVWR $30,963,000.00
  • Revenue This Year
  • COGT N/A
  • LVWR $3.44
  • Revenue Next Year
  • COGT N/A
  • LVWR $136.41
  • P/E Ratio
  • COGT N/A
  • LVWR N/A
  • Revenue Growth
  • COGT N/A
  • LVWR N/A
  • 52 Week Low
  • COGT $3.67
  • LVWR $5.20
  • 52 Week High
  • COGT $12.61
  • LVWR $12.04
  • Technical
  • Relative Strength Index (RSI)
  • COGT 28.97
  • LVWR 47.27
  • Support Level
  • COGT $9.97
  • LVWR $6.09
  • Resistance Level
  • COGT $11.16
  • LVWR $7.25
  • Average True Range (ATR)
  • COGT 0.78
  • LVWR 0.35
  • MACD
  • COGT -0.25
  • LVWR -0.00
  • Stochastic Oscillator
  • COGT 2.02
  • LVWR 27.74

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling.

About LVWR LiveWire Group Inc.

LiveWire Group Inc is an all-electric vehicle company. It sells electric vehicles and related parts and accessories and apparel in the United States and certain international markets. The company's segment includes Electric Motorcycles and STACYC. LiveWire generates revenue from the sale of electric motorcycles, Parts, accessories and apparel.

Share on Social Networks: